Desmethyl Dabrafenib | CAS 1195765-47-9 - Request Quote
Desmethyl Dabrafenib
| SZ CAT No: | SZ-D120014 |
| CAS No | 1195765-47-9 |
| Mol.F. | C22H18F3N5O2S2 |
| Mol.Wt. | 505.5 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Desmethyl Dabrafenib is chemically N-(3-(5-(2-Aminopyrimidin-4-yl)-2-isopropylthiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide. Desmethyl Dabrafenib is supplied with detailed characterization data compliant with regulatory guideline. Desmethyl Dabrafenib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabrafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1195765-47-9
Purchase 1195765-47-9
Order 1195765-47-9
Enquire 1195765-47-9
price of 1195765-47-9
1195765-47-9 Supplier
1195765-47-9 Manufacturer
1195765-47-9 Exporter
buy high quality Desmethyl Dabrafenib
Purchase Desmethyl Dabrafenib
Desmethyl Dabrafenib suppliers
Desmethyl Dabrafenib manufacturers
Desmethyl Dabrafenib price
Order Desmethyl Dabrafenib
Enquire Desmethyl Dabrafenib
Desmethyl Dabrafenib cost
Desmethyl Dabrafenib Supplier
Desmethyl Dabrafenib Distributor
Desmethyl Dabrafenib for Method Validation
Dabrafenib Reference Standard
Desmethyl Dabrafenib for ANDA Filing
Desmethyl Dabrafenib for Forced Degradation Studies
Desmethyl Dabrafenib Identification Standards
Desmethyl Dabrafenib for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.